Screener
ResMed RMD EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from ResMed’s reported figures.
Based on trailing twelve months.
The source filing: ResMed’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 6:19 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000943819-26-000025
FAQ
- What is ResMed's EBITDA margin?
- ResMed (RMD) reported EBITDA margin of 38.2% in Q1 2026.
- How has ResMed's EBITDA margin changed year-over-year?
- ResMed's EBITDA margin increased by 7.0% year-over-year, from 35.7% to 38.2%.
- What is the long-term trend for ResMed's EBITDA margin?
- Over 4 years (2021 to 2025), ResMed's EBITDA margin has grown at a 2.5% compound annual growth rate (CAGR), from 33.2% to 36.6%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about ResMed's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude